Citation(s)
- Kil J, Harruff EE, Longenecker RJ
Development of ebselen for the treatment of sensorineural hearing loss and tinnitus. Hear Res. 2021 Feb 19:108209. doi: 10.1016/j.heares.2021.108209. [Epub ahead of print]
- Kil J, Pierce C, Tran H, Gu R, Lynch ED
Ebselen treatment reduces noise induced hearing loss via the mimicry and induction of glutathione peroxidase. Hear Res. 2007 Apr;226(1-2):44-51. Epub 2006 Oct 6.
- Lynch E, Kil J
Development of ebselen, a glutathione peroxidase mimic, for the prevention and treatment of noise-induced hearing loss. Semin Hear 2009; 30(1):47-55.
Phase 1b Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of SPI-1005 in Meniere's Disease
Details for clinical trial NCT02603081
